{"record_key":"vuessence","identifier":"vuessence","external_key":null,"title":"VuEssence","summary":null,"url":"https://inventions.pitt.edu/startups/vuessence","json_url":"https://inventions.pitt.edu/startups/vuessence.json","object_key":"startups","description":"VuEssence develops molecular diagnostic solutions for stroke, using gene expression blood tests and machine learning to help clinicians assess patients with suspected stroke. [1]: https://vuessence.com/\nThe company was founded in 2010 by Maha Sallam, who serves as president, and is based in Odessa, Florida. It is working toward a blood test that returns stroke-specific gene expression results in under 15 minutes, with a long-term goal of a portable device for ambulances. It has worked with USF Health Neurology on a pilot study of its stroke test. [2]: https://hscweb3.hsc.usf.edu/blog/2019/07/09/usf-health-neurology-and-vuessence-collaborate-on-stroke-early-detection-test/","attributes":[{"key":"website","label":"Website","values":["https://www.vuessence.com"]},{"key":"sector","label":"Sector","values":["Diagnostic"]},{"key":"therapeutic_areas","label":"Therapeutic Areas","values":["Neuroscience"]},{"key":"therapeutic_indications","label":"Therapeutic Indications","values":["Stroke"]},{"key":"funding_stage","label":"Funding Stage","values":["Pre-Seed"]},{"key":"founders","label":"Founders","values":["Maha Sallam"]}],"related":[]}